Specialty Pharmacy

A drug typically used to treat herpes may reduce HIV-1 levels, even in those who don't have herpes.

The agency is slated to review the new drug application within a 6-month timeframe.

Report finds suppliers could spur investment through methods that include equipment leases or supplier-financed credit.

Treatment can selectively drop medication at the site of tumors.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the services his company offers.

Historical comparison shows advantage in virologic response for patients with genotype 1 hepatitis C.

Survivors of breast cancer more likely to develop aggressive form of thyroid cancer.

More than 90% of HIV transmissions originate from undiagnosed and untreated individuals. On the other hand, those retained in medical care who have achieved viral suppression are 94% less likely to transmit HIV.

Study finds older patients and minorities less likely to receive treatment.

Study finds depression in African American cancer patients has gone under-recognized.

Newly characterized compounds found to block inflammation and nerve cell damage.

Regulatory agencies recommend continuous temperature tracking with digital devices over traditional analog models.

Taking multiple medications, having hypertension, and executing heavy labor at work are all associated with a lower sperm count among men attempting to conceive.

David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, debunks what he thinks are the 3 biggest compounding pharmacy myths.

Study evaluates how antiretroviral therapy effects gut microbiota.

Average period to disease recurrence same as with placebo.

Owners prohibited from manufacturing, holding, or distributing sterile drugs until they comply with the Federal Food, Drug, and Cosmetic Act.

Economic variables impact breast cancer treatment, study finds.

Repair rate of intestinal lining dependent on interactions within the gut.

The FDA today approved the first available treatment option for patients with high-risk neuroblastoma.

The FDA has granted priority review to investigational cobimetinib in combination with vemurafenib (Zelboraf) in advanced melanoma.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.

Supplemental oxygenation may shrink tumors and enhance cancer immunotherapy.

Taste pathway changes in patients on chemotherapy for basal cell carcinoma.

Patients found to less antioxidant and anti-inflammatory nutrients.

Study argues for more balanced information for patients before making a treatment decision.

Biosimilars are finally a reality in the US drug market, but a report warns regulatory decisions may limit future savings from the drugs.